<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01455961</url>
  </required_header>
  <id_info>
    <org_study_id>VD-NS-1101</org_study_id>
    <nct_id>NCT01455961</nct_id>
  </id_info>
  <brief_title>An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder</brief_title>
  <acronym>REED</acronym>
  <official_title>An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder Treated With Quetiapine XR and/or Quetiapine IR</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to describe the treatment pattern and patient characteristics in
      real life setting in patients with Bipolar disorder treated with Seroquel XR and/or Seroquel
      IR in Sweden.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An epidemiological registry study to evaluate clinical practice treatment in patients with
      Bipolar Disorder treated with quetiapine XR and/or quetiapine IR
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Description of detailed clinical treatment in terms of duration of treatment, doses, drug switches, and add-on therapy, in patients with BD and on treatment with quetiapine XR and/or quetiapine IR before, at and after the index date.</measure>
    <time_frame>1st of January 2009 to 31st of December 2010.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Description of co-morbidity, demographics, sick leave, early retirement and socioeconomic factors in patients with BD and on treatment with quetiapine XR and/or quetiapine IR before and at the index date.</measure>
    <time_frame>1st of January 2009 to 31st of December 2010.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Description of the detailed clinical treatment in terms of duration of treatment, doses, drug switches, and add-on therapy, in patients with BD, including all drug treatment after the index date</measure>
    <time_frame>1st of January 2009 to 31st of December 2010.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Description of co-morbidity, demographics, sick leave, early retirement and socioeconomic factors in patients with BD, including all drug treatment before and at the index date</measure>
    <time_frame>1st of January 2009 to 31st of December 2010.</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">16000</enrollment>
  <condition>Bipolar Disorder</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who have been hospitalised in Sweden at least once since 1987 with a diagnosis
        during hospitalisation of Bipolar Disorder.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a diagnosis of BD.

        Exclusion Criteria:

          -  Patients with a diagnosis of any schizophrenia spectrum disorder after the diagnosis
             of bipolar disorder.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Carlborg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Neuroscience, Karolinska Institutet 171 76 Stockholm</affiliation>
  </overall_official>
  <link>
    <url>http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&amp;studyid=1139&amp;filename=CSR-VD-NS-1101.pdf</url>
  </link>
  <link>
    <url>http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&amp;studyid=1139&amp;filename=REED_NCT01455961_Redacted_protocol.pdf</url>
    <description>Redacted_protocol</description>
  </link>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2011</study_first_submitted>
  <study_first_submitted_qc>October 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2011</study_first_posted>
  <last_update_submitted>August 20, 2014</last_update_submitted>
  <last_update_submitted_qc>August 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Real life setting</keyword>
  <keyword>Bipolar Disorder</keyword>
  <keyword>Registry based Data Base Audit</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Bipolar Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

